propafenone has been researched along with Orphan Diseases in 1 studies
Propafenone: An antiarrhythmia agent that is particularly effective in ventricular arrhythmias. It also has weak beta-blocking activity.
propafenone : An aromatic ketone that is 3-(propylamino)propane-1,2-diol in which the hydrogen of the primary hydroxy group is replaced by a 2-(3-phenylpropanoyl)phenyl group. It is a class 1C antiarrhythmic drug with local anesthetic effects, and is used as the hydrochloride salt in the management of supraventricular and ventricular arrhythmias.
Orphan Diseases: Rare diseases that have not been well studied.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wei, J | 1 |
| Li, Y | 1 |
| Li, R | 1 |
| Chen, X | 1 |
| Yang, T | 1 |
| Liao, L | 1 |
| Xie, Y | 1 |
| Zhu, J | 1 |
| Mao, F | 1 |
| Jia, R | 1 |
| Xu, X | 1 |
| Li, J | 1 |
1 other study available for propafenone and Orphan Diseases
| Article | Year |
|---|---|
Drug repurposing of propafenone to discover novel anti-tumor agents by impairing homologous recombination to delay DNA damage recovery of rare disease conjunctival melanoma.
Topics: Antineoplastic Agents; Cell Cycle Proteins; DNA Damage; DNA Repair; DNA Repair Enzymes; Drug Reposit | 2023 |